Concepedia

Publication | Open Access

Phase IA/IB study of single-agent tislelizumab, an investigational anti-PD-1 antibody, in solid tumors

145

Citations

15

References

2020

Year

Abstract

NCT02407990.

References

YearCitations

Page 1